Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial

BACKGROUND: Comparison of changes in body composition, adipokines and inflammatory markers after initial therapy with a nucleos(t)ide reverse transcriptase inhibitor (N(t)RTI)- sparing or containing regimen are scarce. DESIGN: Randomised Clinical Trial. METHODS: This is the body composition substudy...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernardino, Jose I., Mocroft, Amanda, Wallet, Cedrick, de Wit, Stéphane, Katlama, Christine, Reiss, Peter, Mallon, Patrick W., Richert, Laura, Molina, Jean-Michel, Knobel, Hernando, Morlat, Philippe, Babiker, Abdel, Pozniac, Anton, Raffi, Francois, Arribas, Jose R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349314/
https://www.ncbi.nlm.nih.gov/pubmed/30689664
http://dx.doi.org/10.1371/journal.pone.0209911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349314/
https://www.ncbi.nlm.nih.gov/pubmed/30689664
http://dx.doi.org/10.1371/journal.pone.0209911

Ejemplares similares